ENTITY

Insulet Corp (PODD US)

84
Analysis
Health Care • United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullish•Eoflow
•06 Oct 2023 12:39

EOFlow: Insulet's Injunction Doesn't Thwart Medtronic's Acquisition

t makes commercial sense for MDT to complete the EOFlow transaction on schedule, enabling the more financially and legally resource-rich MDT to...

Logo
1.4k Views
Share
bullish•Eoflow
•05 Oct 2023 20:25

Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?

Eoflow's share price has dropped 27% lower than the proposed tender offer price of 30,000 won. In this insight, we discuss two major factors have...

Logo
1.3k Views
Share
bullish•Nws Holdings
•02 Oct 2023 00:13

Merger Arb Mondays (02 Oct) - NWS, Mason, IMAX China, Keiyo, System Info, Toyo, Symbio, Allkem

This week, the highest gross spreads are Keiyo (58.3%), 111 (40.8%), Eoflow (22.4%), Symbio (19.3%), IMAX China (19.0%), JSR (8.3%), Boustead...

Logo
4k Views
Share
bullish•ENM Holdings
•25 Sep 2023 00:21

Merger Arb Mondays (25 Sep) - ENM, Poly Culture, Eoflow, Origin Energy, Symbio, Costa, InvoCare

This week, the highest gross spreads are 111 (48.9%), Eoflow (23.7%), Symbio (10.7%), Mason Group (9.0%), JSR (7.8%), DDH1 (6.0%), ENM (5.5%),...

Logo
739 Views
Share
bearish•Tandem Diabetes Care
•21 Sep 2023 16:49

Tandem Diabetes Care (TNDM US): Q2 Sales Declined, Margin Deteriorated; 2023 Guidance Revised Lower

​Tandem's Q2 sales declined 2% YoY to $195.9M, as global pump shipment plummeted 8% YoY to 29,494. The company has lowered 2023 sales guidance to...

Logo
517 Views
Share
x